| Year |
Citation |
Score |
| 2022 |
Khan A, Lindenmayer JP, Insel B, Seddo M, Demirli E, DeFazio K, Sullivan M, Hoptman MJ, Ahmed AO. Computerized cognitive and social cognition training in schizophrenia for impulsive aggression. Schizophrenia Research. PMID 36424289 DOI: 10.1016/j.schres.2022.11.004 |
0.357 |
|
| 2021 |
Lindenmayer JP, Insel BJ, Khan A, Osborne M, Goldring A, Seddo M. Effects of Clozapine on Neurocognitive Functions in Schizophrenia: A Naturalistic Comparison to Non-clozapine Antipsychotics. Innovations in Clinical Neuroscience. 18: 40-46. PMID 35096483 |
0.369 |
|
| 2020 |
Goldring A, Borne S, Hefner A, Thanju A, Khan A, Lindenmayer JP. The psychometric properties of the Self-Evaluation of Negative Symptoms Scale (SNS) in treatment-resistant schizophrenia (TRS). Schizophrenia Research. PMID 33071071 DOI: 10.1016/j.schres.2020.08.008 |
0.33 |
|
| 2020 |
Lindenmayer JP, Goldring A, Borne S, Khan A, Keefe RSE, Insel BJ, Thanju A, Ljuri I, Foreman B. Assessing instrumental activities of daily living (iADL) with a game-based assessment for individuals with schizophrenia. Schizophrenia Research. PMID 32690346 DOI: 10.1016/J.Schres.2020.07.001 |
0.402 |
|
| 2020 |
Sevy S, Lindenmayer JP, Khan A, Ljuri I, Kulsa MKC, Jones O. Differential improvement of negative-symptom subfactors after cognitive remediation in low-functioning individuals with schizophrenia. Schizophrenia Research. Cognition. 19: 100145. PMID 31828020 DOI: 10.1016/J.Scog.2019.100145 |
0.472 |
|
| 2020 |
Lindenmayer J, Khan A, Dagum P, Mena E, Yu J, Seddo M, Padua T, Schaf B. S105. Digital Biomarkers For The Assessment Of Cognitive, Behavioral And Functional Outcomes In Individuals With Schizophrenia Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa031.171 |
0.446 |
|
| 2020 |
Ahmed A, Dihmes SE, Kirstie-Kulsa M, Hefner A, Ljuri I, Seddo M, Pistillo T, Khan A, Hoptman M, Lindenmayer J. S50. COGNITION AND EMOTION REGULATION IN SCHIZOPHRENIA PATIENTS WITH A HISTORY OF AGGRESSION Schizophrenia Bulletin. 46: S51-S52. DOI: 10.1093/Schbul/Sbaa031.116 |
0.349 |
|
| 2020 |
Lindenmayer J, Khan A, Harvey P, Keefe R, Liharska L, Yavorsky C, Seddo M. M120. IMPAIRED CLINICAL INSIGHT AS A PREDICTOR OF RELAPSE IN SCHIZOPHRENIA Schizophrenia Bulletin. 46: S180-S181. DOI: 10.1093/Schbul/Sbaa030.432 |
0.418 |
|
| 2020 |
Chamali R, Ghuloum S, Sheehan DV, Mahfoud Z, Yehya A, Opler MGA, Khan A, Hammoudeh S, Hani Y, Al-Amin H. Cross-Validation of the Arabic Mini International Neuropsychiatric Interview, Module K, for Diagnosis of Schizophrenia and the Arabic Positive and Negative Syndrome Scale Journal of Psychopathology and Behavioral Assessment. 42: 139-149. DOI: 10.1007/S10862-019-09759-6 |
0.424 |
|
| 2019 |
Harvey PD, Khan A, Atkins A, Walker TM, Keefe RSE. Comprehensive review of the research employing the schizophrenia cognition rating scale (SCoRS). Schizophrenia Research. PMID 31196736 DOI: 10.1016/J.Schres.2019.05.040 |
0.511 |
|
| 2019 |
Amro I, Ghuloum S, Mahfoud Z, Opler M, Khan A, Hammoudeh S, Hani Y, Yehya A, Al-Amin H. Cross-cultural adaptation of the Arabic Positive and Negative Syndrome Scale in schizophrenia: Qualitative analysis of a focus group. Transcultural Psychiatry. 1363461519850345. PMID 31130104 DOI: 10.1177/1363461519850345 |
0.456 |
|
| 2019 |
Harvey PD, Khan A, Atkins A, Keefe RS. Virtual reality assessment of functional capacity in people with Schizophrenia: Associations with reduced emotional experience and prediction of functional outcomes. Psychiatry Research. PMID 30679049 DOI: 10.1016/J.Psychres.2019.01.045 |
0.39 |
|
| 2019 |
Harvey P, Khan A, Atkins A, Keefe R. O5.7. VIRTUAL REALITY FUNCTIONAL CAPACITY ASSESSMENT IN PATIENTS WITH SCHIZOPHRENIA: CORRELATES OF PERFORMANCE OF SOLITARY AND SOCIALLY RELEVANT TASKS Schizophrenia Bulletin. 45: S175-S175. DOI: 10.1093/Schbul/Sbz021.216 |
0.386 |
|
| 2019 |
Lucic L, Khan A, Sommer M, Yavorsky C, Khalique R, Lindenmayer J, Ljuri I, Yoon J, Dagum P, Yu J. T56. An Electronic Patient-Reported Outcomes Symptom Measure (Epro) For Assessing Awareness Of Insight In Chronic Schizophrenia Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz019.336 |
0.394 |
|
| 2019 |
Goldring A, Lindenmayer J, Hefner A, Khan A, Thanju A, Foreman B, Jones O, Romano A, Parak M, Parker B. T40. CAN SCHIZOPHRENIA PATIENTS RELIABLY REPORT NEGATIVE SYMPTOMS? A PILOT STUDY USING THE SELF-EVALUATION OF NEGATIVE SYMPTOMS SCALE Schizophrenia Bulletin. 45: S218-S219. DOI: 10.1093/Schbul/Sbz019.320 |
0.419 |
|
| 2019 |
Lindenmayer J, Khan A, Ljuri I, Jones O, Yoon J, Hefner A, Budgazad M, Parker B, Parak M, Gill H, Kirstie-Kulsa M, Thanju A, Hoptman M, Ahmed A, Goldring A. T37. COGNITIVE TRAINING FOR SOCIAL COGNITION IN IMPULSIVE AGGRESSION IN SCHIZOPHRENIA Schizophrenia Bulletin. 45: S217-S218. DOI: 10.1093/Schbul/Sbz019.317 |
0.438 |
|
| 2019 |
Ahmed A, Kirstie-Kulsa M, Hefner A, Jones O, Ljuri I, Budgazad M, Parker B, Parak M, Lee C, Yoon J, Gill H, Khan A, Hoptman M, Lindenmayer J. F43. COGNITIVE TRAINING FOR IMPULSIVE AGGRESSION IN SCHIZOPHRENIA Schizophrenia Bulletin. 45: S271-S272. DOI: 10.1093/Schbul/Sbz018.455 |
0.419 |
|
| 2019 |
Lindenmayer J, Goldring A, Khan A, Foreman B, Thanju A, Perugula M, Jones O, Begum G, Yang R, Sahib J, Ljuri I, Yoon J, Hefner A, Parker B, Borne S. F32. Psychometric And Predictive Validity Of The Virtual Reality Functional Capacity Assessment Tool (Vrfcat) In Individuals With Chronic Schizophrenia Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz018.444 |
0.387 |
|
| 2019 |
Welsh-Bohmer KA, Atkins AS, Plassman BL, Khan A, Chiang C, Culp M, O'Neil J, Walter R, Haneline S, Arbuckle J, Brewster S, Maruyama Y, Swanson T, Hayden KM, Romero H, et al. O4-11-02: DEFINING COGNITION IN PRE-DEMENTIA CLINICAL TRIALS: BASELINE NEUROPSYCHOLOGICAL DATA FROM THE TOMMORROW STUDY Alzheimer's & Dementia. 15: P1262-P1262. DOI: 10.1016/J.Jalz.2019.06.4801 |
0.33 |
|
| 2018 |
Taher A, Viprakasit V, Cappellini MD, Sutcharitchan P, Ward R, Mahmoud D, Laadem A, Khan A, Gwaltney C, Harding G, Attie K, Zhang X, Zou J, Pariseau J, Hu XH, et al. Development of a patient-reported outcomes symptom measure for patients with non-transfusion-dependent thalassemia (NTDT-PRO©). American Journal of Hematology. PMID 30394579 DOI: 10.1002/Ajh.25343 |
0.345 |
|
| 2018 |
Lindenmayer JP, Kulsa MKC, Sultana T, Kaur A, Yang R, Ljuri I, Parker B, Khan A. Transcranial direct-current stimulation in ultra-treatment-resistant schizophrenia. Brain Stimulation. PMID 30316742 DOI: 10.1016/J.Brs.2018.10.002 |
0.364 |
|
| 2018 |
Lindenmayer JP, Khan A, McGurk SR, Kulsa MKC, Ljuri I, Ozog V, Fregenti S, Capodilupo G, Buccellato K, Thanju A, Goldring A, Parak M, Parker B. Does social cognition training augment response to computer-assisted cognitive remediation for schizophrenia? Schizophrenia Research. PMID 29910120 DOI: 10.1016/J.Schres.2018.06.012 |
0.431 |
|
| 2018 |
Keefe RSE, Harvey PD, Khan A, Saoud JB, Staner C, Davidson M, Luthringer R. Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms: Results From a Randomized Controlled Trial. The Journal of Clinical Psychiatry. 79. PMID 29873956 DOI: 10.4088/Jcp.17M11753 |
0.492 |
|
| 2018 |
Lindenmayer J, Goldring A, Hefner A, Khan A, Thanju A. S213. CAN PATIENTS WITH TREATMENT RESISTANT SCHIZOPHRENIA RELIABLY REPORT NEGATIVE SYMPTOMS? A PILOT STUDY USING THE SELF-EVALUATION OF NEGATIVE SYMPTOMS SCALE Schizophrenia Bulletin. 44: S408-S409. DOI: 10.1093/Schbul/Sby018.1000 |
0.461 |
|
| 2018 |
Khan A, Lindenmayer J, Ljuri I, Ozog V, Thanju A. F143. PREDICTORS OF RELAPSE: PATIENT, DISEASE, COGNITIVE, AND FUNCTIONAL CHARACTERISTICS WITH COMT GENE VAL158MET POLYMORPHISM IN A 2-YEAR FOLLOW-UP Schizophrenia Bulletin. 44: S275-S275. DOI: 10.1093/Schbul/Sby017.674 |
0.324 |
|
| 2018 |
Sevy S, Khan A, Lindenmayer J, McGurk S, Paker B, Ljuri I, Parak M, Goldring A. F63. COGNITIVE CORRELATES OF THE NEGATIVE SYMPTOMS EXPRESSIVE AND EXPERIENTIAL DEFICIT FACTORS IN PSYCHOSIS Schizophrenia Bulletin. 44: S244-S244. DOI: 10.1093/Schbul/Sby017.594 |
0.438 |
|
| 2018 |
Khan A, Liharska L, Harvey P, Atkins A, Keefe R, Ulshen D. T111. PANSS NEGATIVE SYMPTOM DIMENSIONS ACROSS GEOGRAPHICAL REGIONS: IMPLICATIONS FOR SOCIAL, LINGUISTIC AND CULTURAL CONSISTENCY Schizophrenia Bulletin. 44: S159-S159. DOI: 10.1093/Schbul/Sby016.387 |
0.302 |
|
| 2018 |
Lindenmayer J, Sultana T, Kaur A, Yang R, Khan A, Kirstie-Kulsa M, Ljuri I, Parker B. T43. Transcranial Direct-Current Stimulation (Tdcs) In Patients With Ultra-Treatment-Refractory Auditory Hallucinations. Schizophrenia Bulletin. 44. DOI: 10.1093/Schbul/Sby016.319 |
0.401 |
|
| 2018 |
Sevy S, Lindenmayer J, Khan A, McGurk SR, Ljuri I, Thanju A, Goldring A, Parak M, Parker B. F203. Differential Cognitive Deficits of Two Negative Symptom Domains in Schizophrenia Biological Psychiatry. 83: S318. DOI: 10.1016/J.Biopsych.2018.02.817 |
0.45 |
|
| 2017 |
Khan A, Liharska L, Harvey PD, Atkins A, Ulshen D, Keefe RSE. Negative Symptom Dimensions of the Positive and Negative Syndrome Scale Across Geographical Regions: Implications for Social, Linguistic, and Cultural Consistency. Innovations in Clinical Neuroscience. 14: 30-40. PMID 29410935 |
0.31 |
|
| 2017 |
Yehya A, Ghuloum S, Mahfoud Z, Opler M, Khan A, Hammoudeh S, Hani Y, Al-Amin H. Validation of the Five-Factor Model of the Arabic Version of the Positive and Negative Syndrome Scale in Schizophrenia. Psychopathology. PMID 28514778 DOI: 10.1159/000472154 |
0.471 |
|
| 2017 |
Georgiades A, Davis VG, Atkins AS, Khan A, Walker TW, Loebel A, Haig G, Hilt DC, Dunayevich E, Umbricht D, Sand M, Keefe RSE. Psychometric characteristics of the MATRICS Consensus Cognitive Battery in a large pooled cohort of stable schizophrenia patients. Schizophrenia Research. PMID 28433500 DOI: 10.1016/J.Schres.2017.03.040 |
0.45 |
|
| 2017 |
Lindenmayer JP, Ozog VA, Khan A, Ljuri I, Fregenti S, McGurk SR. Predictors of response to cognitive remediation in service recipients with severe mental illness. Psychiatric Rehabilitation Journal. 40: 61-69. PMID 28368180 DOI: 10.1037/Prj0000252 |
0.418 |
|
| 2017 |
Rabinowitz J, Schooler NR, Anderson A, Ayearst L, Daniel D, Davidson M, Khan A, Kinon B, Menard F, Opler L, Opler M, Severe JB, Williamson D, Yavorsky C, Zhao J, et al. Consistency checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS). Schizophrenia Research. PMID 28285023 DOI: 10.1016/J.Schres.2017.03.017 |
0.313 |
|
| 2017 |
Lindenmayer JP, Fregenti S, Kang G, Ozog V, Ljuri I, Khan A, Goldring A, McGurk SR. The relationship of cognitive improvement after cognitive remediation with social functioning in patients with schizophrenia and severe cognitive deficits. Schizophrenia Research. PMID 28094171 DOI: 10.1016/J.Schres.2017.01.007 |
0.473 |
|
| 2017 |
Khan A, Lindenmayer J, Ljuri I, Capodilupo G, Buccellato K, Ozog V, Yang R. SU36. Effects of Change in Psychopathology on Change in Social Cognition After CRT Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx024.034 |
0.333 |
|
| 2017 |
Thanju A, Lindenmayer J, Khan A. SA3. Association of ZNF804A rs1344706 Genotype and Impulsivity in Patients With Chronic Schizophrenia. Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx023.002 |
0.362 |
|
| 2017 |
Atkins A, Tseng T, Vaughan A, Harvey P, Narasimhan M, Patterson T, Khan A, Keefe R. M25. Development and Validation of the Brief Assessment of Validation in Schizophrenia (BAC-App) Schizophrenia Bulletin. 43: S220-S220. DOI: 10.1093/Schbul/Sbx022.024 |
0.406 |
|
| 2017 |
Goldring A, Lindenmayer J, Khan A, Foreman B, Yang R, Ozog V. M24. Assessing Functional Impairment in Treatment-Resistant Schizophrenia Using the Virtual Reality Functional Capacity Assessment Tool (VRFCAT): A Pilot Study Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx022.023 |
0.398 |
|
| 2017 |
Lindenmayer J, Khan A, Ljuri I, Goldring A, McGurk SR, Ozog V, Capodilupo G. 218. Top-Down or Bottom-Up? Comparison of Two Computer-Assisted Modalities of Cognitive Remediation Therapy for Schizophrenia Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx021.296 |
0.464 |
|
| 2017 |
Atkins AS, Khan A, Welsh-Bohmer KA, Plassman BL, Randolph C, Harrison J, Keefe RS. EXPANDING THE BRIEF ASSESSMENT OF COGNITION (BAC-APP) FOR ASSESSMENT OF COGNITION IN AGING: INITIAL FINDINGS FROM AN ONGOING NORMATIVE STUDY Alzheimer's & Dementia. 13: P1574-P1575. DOI: 10.1016/J.Jalz.2017.07.741 |
0.38 |
|
| 2017 |
Lucic L, Khan A, Daiute C. Can writing be used to study and improve the socio-cognitive functioning of individuals diagnosed with schizophrenia? European Psychiatry. 41: s821-s821. DOI: 10.1016/J.Eurpsy.2017.01.1600 |
0.454 |
|
| 2016 |
Hammoudeh S, Ghuloum S, Mahfoud Z, Opler M, Khan A, Yehya A, Abdulhakam A, Al-Mujalli A, Hani Y, Elsherbiny R, Al-Amin H. Reliability, validity and factorial structure of the Arabic version of the international suicide prevention trial (InterSePT) scale for suicidal thinking in schizophrenia patients in Doha, Qatar. Bmc Psychiatry. 16: 437. PMID 27927173 DOI: 10.1186/S12888-016-1155-4 |
0.392 |
|
| 2016 |
Hani Y, Ghuloum S, Mahfoud Z, Opler M, Khan A, Yehya A, Abdulhakam A, Hammoudeh S, Al-Mujalli A, Elsherbiny R, Al-Amin H. Validation of the Arabic Version of Calgary Depression Scale for Schizophrenia. Plos One. 11: e0162304. PMID 27583831 DOI: 10.1371/Journal.Pone.0162304 |
0.422 |
|
| 2016 |
Yehya A, Ghuloum S, Mahfoud Z, Opler M, Khan A, Hammoudeh S, Abdulhakam A, Al-Mujalli A, Hani Y, Elsherbiny R, Al-Amin H. Validity and Reliability of the Arabic Version of the Positive and Negative Syndrome Scale. Psychopathology. 49. PMID 27475457 DOI: 10.1159/000447328 |
0.401 |
|
| 2016 |
Khan A, Atkins AS, Stroescu I, Davis V, Williamson T, Mozley LH, Voss T, McMahon KB, Keefe RS. P4-291: Assessing the Impact of a Centralized Data Review on the Reliability of the Alzheimer’S Disease Assessment Scale-Cognitive (ADAS-COG) Alzheimer's & Dementia. 12: P1145-P1145. DOI: 10.1016/J.Jalz.2016.07.033 |
0.373 |
|
| 2015 |
Lindenmayer JP, Khan A, Lachman H, McGurk SR, Goldring A, Thanju A, Kaushik S. COMT genotype and response to cognitive remediation in schizophrenia. Schizophrenia Research. PMID 26255563 DOI: 10.1016/J.Schres.2015.07.037 |
0.442 |
|
| 2015 |
Lucic L, Khan A, Liharska L, Rothman B. What Can We Learn About Psycho-social Functioning of Individuals Diagnosed with Schizophrenia From Standardized Patients? European Psychiatry. 30: 1286. DOI: 10.1016/S0924-9338(15)31005-1 |
0.464 |
|
| 2015 |
Lucic L, Daiute C, Khan A. Narrative Exploration of Social Cognition in Adults Hospitalized Due to Symptoms of Schizophrenia European Psychiatry. 30: 1282. DOI: 10.1016/S0924-9338(15)31004-X |
0.348 |
|
| 2014 |
Lucic L, Khan A, Rothman B, Gao L, Peterson T, Opler M. EPA-0121 – How to measure social cognition in schizophrenia? a comparison of measurements European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)77595-9 |
0.463 |
|
| 2014 |
Ivanova E, Reznik A, Opler M, Khan A, Gao L. EPA-0120 – Validation and normalization of the russian version of the positive and negative syndrome scale (PANSS-RU) in schizophrenia: preliminary findings European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)77594-7 |
0.402 |
|
| 2014 |
Lucic L, Khan A, Colette D. Poster #T145 “I AM HERE BECAUSE THE VOICES CAME BACK …”: NARRATIVE EXPLORATION OF THE FUNCTION OF CONCEPT FORMATION IN ADULTS HOSPITALIZED DUE TO SYMPTOMS OF SCHIZOPHRENIA Schizophrenia Research. 153: S341. DOI: 10.1016/S0920-9964(14)70962-4 |
0.366 |
|
| 2014 |
Gao L, Khan A, Lucic L, Rothman B. Poster #M207 USE OF RELIABLE CHANGE INDEX TO EVALUATE CLINICAL SIGNIFICANCE IN THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS): A CATIE ANALYSIS Schizophrenia Research. 153: S265. DOI: 10.1016/S0920-9964(14)70757-1 |
0.317 |
|
| 2014 |
Lucić L, Khan A, Yavorsky C, Rothman B. Poster #S258 TEACHING AND LEARNING THE DISCOURSE OF SCHIZOPHRENIA: DEVELOPMENT OF A STANDARDIZED PATIENT TRAINING PROGRAM Schizophrenia Research. 153: S183-S184. DOI: 10.1016/S0920-9964(14)70537-7 |
0.343 |
|
| 2014 |
Khan A, Lindenmayer JP, Opler M, Kelley ME, White L, Compton M, Gao Z, Harvey PD. The evolution of illness phases in schizophrenia: A non-parametric item response analysis of the Positive and Negative Syndrome Scale Schizophrenia Research: Cognition. 1: 53-89. DOI: 10.1016/J.Scog.2014.01.002 |
0.413 |
|
| 2014 |
Farrell M, Khan A, Rothman B, Opler M, Karantzoulis S. P4-355: USING RELIABLE CHANGE INDEX (RCI) AND CLINICAL CHANGE TO PREDICT COGNITIVE OUTCOME IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P918-P919. DOI: 10.1016/J.Jalz.2014.07.125 |
0.322 |
|
| 2013 |
Khan A, Yavorsky C, Liechti S, Opler M, Rothman B, DiClemente G, Lucic L, Jovic S, Inada T, Yang L. A rasch model to test the cross-cultural validity in the positive and negative syndrome scale (PANSS) across six geo-cultural groups. Bmc Psychology. 1: 5. PMID 25566357 DOI: 10.1186/2050-7283-1-5 |
0.316 |
|
| 2013 |
Khan A, Yavorsky C, DiClemente G, Opler M, Liechti S, Rothman B, Jovic S. Reliability of the Alzheimer's disease assessment scale (ADAS-Cog) in longitudinal studies. Current Alzheimer Research. 10: 952-63. PMID 24117118 DOI: 10.2174/15672050113106660160 |
0.355 |
|
| 2013 |
Khan A, Lindenmayer JP, Opler M, Yavorsky C, Rothman B, Lucic L. A new Integrated Negative Symptom structure of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia using item response analysis. Schizophrenia Research. 150: 185-96. PMID 23911252 DOI: 10.1016/J.Schres.2013.07.007 |
0.439 |
|
| 2013 |
Khan A, Yavorsky WC, Liechti S, DiClemente G, Rothman B, Opler M, DeFries A, Jovic S. Assessing the sources of unreliability (rater, subject, time-point) in a failed clinical trial using items of the Positive and Negative Syndrome Scale (PANSS). Journal of Clinical Psychopharmacology. 33: 109-17. PMID 23277234 DOI: 10.1097/Jcp.0B013E3182776Ebe |
0.373 |
|
| 2013 |
Lindenmayer JP, McGurk SR, Khan A, Kaushik S, Thanju A, Hoffman L, Valdez G, Wance D, Herrmann E. Improving social cognition in schizophrenia: a pilot intervention combining computerized social cognition training with cognitive remediation. Schizophrenia Bulletin. 39: 507-17. PMID 23125396 DOI: 10.1093/Schbul/Sbs120 |
0.433 |
|
| 2013 |
Yavorsky C, Opler M, Jovic S, Lucic L, Rothman B, Khan A. P2-315: Effects of biomarkers on cognitive domains in Alzheimer's disease Alzheimer's & Dementia. 9: P474-P474. DOI: 10.1016/J.Jalz.2013.05.963 |
0.315 |
|
| 2013 |
Khan A, Yavorsky C, Opler M, Jovic S. P2-281: Differential item functioning and the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) among people with Alzheimer's disease Alzheimer's & Dementia. 9: P460-P461. DOI: 10.1016/J.Jalz.2013.05.928 |
0.35 |
|
| 2012 |
Lindenmayer JP, Khan A, Kaushik S, Thanju A, Praveen R, Hoffman L, Cherath L, Valdez G, Wance D. Relationship between metabolic syndrome and cognition in patients with schizophrenia. Schizophrenia Research. 142: 171-6. PMID 23106932 DOI: 10.1016/J.Schres.2012.09.019 |
0.463 |
|
| 2012 |
Lindenmayer JP, Tedeschi F, Yusim A, Khan A, Kaushik S, Smith RC, Parakadavil M. Ziprasidone's effect on metabolic markers in patients with diabetes and chronic schizophrenia. Clinical Schizophrenia & Related Psychoses. 5: 185-92. PMID 22182455 DOI: 10.3371/Csrp.5.4.2 |
0.339 |
|
| 2012 |
Rothman B, Khan A, Opler M, Bhargava L. P-1301 - Cross-cultural differences in the positive and negative syndrome scale (PANSS) among european and japanese raters European Psychiatry. 27: 1. DOI: 10.1016/S0924-9338(12)75468-8 |
0.359 |
|
| 2012 |
Yavorsky C, Opler M, Di Clemente G, De Fries A, Khan A, Jovic S. P-463 - Development of the brief episodic memory assessment (BEMA): a new scale for episodic memory in alzheimer's disease to complement one-plus-one in vivo diagnosis strategy European Psychiatry. 27: 1. DOI: 10.1016/S0924-9338(12)74630-8 |
0.306 |
|
| 2012 |
Lindenmaver J, McGurk SR, Khan A, Thanju A, Kaushik S, Hoffman L, Valdez G, Wance D, Herrmann E. Poster #144 SYSTEMATIZING SOCIAL COGNITION: A COGNITIVE NEUROPSYCHIATRIC PROGRAM OF AN INTEGRATED INTERVENTION ADDRESSING EMOTION RECOGNITION AND SOCIAL INTERACTION USING INTERACTIVE MULTIMEDIA, IN PATIENTS WITH SCHIZOPHRENIA Schizophrenia Research. 136: S332. DOI: 10.1016/S0920-9964(12)70976-3 |
0.421 |
|
| 2012 |
Yavorsky C, Khan A, Leicht S, Rothman B, Opler M, DeFries A. Poster #188 A RASCH MODEL ANALYSIS TO ASSESS CROSS-CULTURAL DIFFERENCES AMONG ITEMS THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) IN SCHIZOPHRENIA Schizophrenia Research. 136: S253. DOI: 10.1016/S0920-9964(12)70759-4 |
0.427 |
|
| 2012 |
Yavorsky C, Khan A, Opler M, DiClemente G, DeFries A, Jovic S. Poster #246 EARLY PATTERNS OF SYMPTOM PROFILES USING THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) TO INFORM DECISIONS ON THE EXPECTED RESPONSE TO TREATMENT DURING CLINICAL TRIALS Schizophrenia Research. 136: S179. DOI: 10.1016/S0920-9964(12)70558-3 |
0.329 |
|
| 2012 |
Yavorsky C, DiClemente G, Opler M, Khan A, Jovic S, Rothman B. P2-428: Establishing threshold scores and profiles of cognitive impairment for the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) for patients with higher dementia (MMSE < 12), Alzheimer's disease and probable MCI Alzheimer's & Dementia. 8: P415-P416. DOI: 10.1016/J.Jalz.2012.05.2053 |
0.378 |
|
| 2011 |
Khan A, Lewis C, Lindenmayer JP. Use of non-parametric item response theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS). Bmc Psychiatry. 11: 178. PMID 22087503 DOI: 10.1186/1471-244X-11-178 |
0.588 |
|
| 2011 |
Lindenmayer JP, Citrome L, Khan A, Kaushik S, Kaushik S. A randomized, double-blind, parallel-group, fixed-dose, clinical trial of quetiapine at 600 versus 1200 mg/d for patients with treatment-resistant schizophrenia or schizoaffective disorder. Journal of Clinical Psychopharmacology. 31: 160-8. PMID 21346616 DOI: 10.1097/Jcp.0B013E31820F4Fe0 |
0.302 |
|
| 2011 |
Lindenmayer JP, Khan A. Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia. Schizophrenia Research. 125: 267-77. PMID 20850275 DOI: 10.1016/J.Schres.2010.08.021 |
0.467 |
|
| 2010 |
Lewis C, Khan A, Souvlis T, Sterling M. A randomised controlled study examining the short-term effects of Strain-Counterstrain treatment on quantitative sensory measures at digitally tender points in the low back. Manual Therapy. 15: 536-41. PMID 20576462 DOI: 10.1016/j.math.2010.05.011 |
0.488 |
|
| 2010 |
Yates KF, Kunz M, Khan A, Volavka J, Rabinowitz S. Psychiatric patients with histories of aggression and crime five years after discharge from a cognitive-behavioral program Journal of Forensic Psychiatry and Psychology. 21: 167-188. DOI: 10.1080/14789940903174238 |
0.305 |
|
| 2008 |
Lindenmayer JP, McGurk SR, Mueser KT, Khan A, Wance D, Hoffman L, Wolfe R, Xie H. A randomized controlled trial of cognitive remediation among inpatients with persistent mental illness. Psychiatric Services (Washington, D.C.). 59: 241-7. PMID 18308903 DOI: 10.1176/PS.2008.59.3.241 |
0.379 |
|
| 2008 |
Lindenmayer J, Kaushik S, Branch C, McGurk S, Khan A, Li H, Hoffman L. Does computerized cognitive remediation change brain activation patterns in schizophrenia: fMRI pilot data European Psychiatry. 23. DOI: 10.1016/J.Eurpsy.2008.01.827 |
0.409 |
|
| 2007 |
Lindenmayer JP, Harvey PD, Khan A, Kirkpatrick B. Schizophrenia: measurements of psychopathology. The Psychiatric Clinics of North America. 30: 339-63. PMID 17720027 DOI: 10.1016/J.Psc.2007.04.005 |
0.456 |
|
| 2007 |
Lindenmayer JP, Khan A, Iskander A, Abad MT, Parker B. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia. The Journal of Clinical Psychiatry. 68: 368-79. PMID 17388705 DOI: 10.4088/Jcp.V68N0303 |
0.448 |
|
| Show low-probability matches. |